ShockWave Medical, Inc. (SWAV)

NASDAQ: SWAV · IEX Real-Time Price · USD
174.33
5.66 (3.36%)
At close: May 27, 2022 4:00 PM
175.58
1.25 (0.72%)
After-hours:May 27, 2022 6:01 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20212020201920182017
Revenue
237.1567.7942.9312.261.72
Revenue Growth (YoY)
249.83%57.92%250.05%613.38%-
Cost of Revenue
41.4420.9917.167.252.84
Gross Profit
195.7146.825.775.01-1.12
Selling, General & Admin
146.0475.5444.7523.5211.79
Research & Development
50.5436.9332.8522.717.96
Operating Expenses
196.58112.4677.6146.2129.75
Operating Income
-0.87-65.66-51.84-41.2-30.87
Interest Expense / Income
1.11.210.940.40.06
Other Expense / Income
6.87-1.26-1.74-0.54-0.33
Pretax Income
-8.84-65.62-51.05-41.06-30.59
Income Tax
0.30.080.060.040.03
Net Income
-9.14-65.7-51.11-41.1-30.62
Net Income Common
-9.14-65.7-51.11-41.1-30.62
Shares Outstanding (Basic)
35332422
Shares Outstanding (Diluted)
35332422
Shares Change
6.07%38.42%1260.47%13.12%-
EPS (Basic)
-0.26-1.99-2.14-23.39-19.71
EPS (Diluted)
-0.26-1.99-2.14-23.39-19.71
Free Cash Flow Per Share
0.07-2.50-2.17-24.73-19.81
Gross Margin
82.53%69.03%60.03%40.88%-64.98%
Operating Margin
-0.37%-96.86%-120.76%-335.97%-1795.52%
Profit Margin
-3.85%-96.92%-119.06%-335.17%-1780.98%
Free Cash Flow Margin
1.10%-122.00%-120.96%-354.29%-1790.11%
Effective Tax Rate
-3.41%-0.12%-0.12%-0.09%-0.08%
EBITDA
-2.2-61.06-47.82-39.96-30.06
EBITDA Margin
-0.93%-90.08%-111.40%-325.88%-1748.87%
EBIT
-7.74-64.41-50.1-40.66-30.53
EBIT Margin
-3.26%-95.01%-116.72%-331.59%-1776.09%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).